A peripheral intravenous catheter (“PIVC”) often needs to be prematurely removed from a patient before an intended IV therapy is complete. A primary factor contributing to the need to prematurely remove a PIVC is mechanical phlebitis, which results when the PIVC moves and irritates the internal anatomy of the patient. A secondary factor contributing to the need to prematurely remove a PIVC is potential introduction of microorganisms when the PIVC moves while within the patient. Mechanical stabilization of PIVCs has been shown to decrease mechanical phlebitis and increase IV-therapy dwell time. However, existing stabilization devices for such PIVCs are not compatible with integrated PIVCs. Thus, the existing stabilization devices cannot provide the mechanical stabilization needed to reduce mechanical phlebitis and enhance the dwell time needed to complete intended IV therapies with integrated PIVCs. Disclosed herein is a stabilization device and methods thereof for integrated catheters such as integrated PIVCs.
Disclosed herein is a stabilization device for integrated catheters including, in some embodiments, a platform, a pair of catheter fasteners on the platform, and a pair of stabilization wings extending from the platform. The platform has a skin-facing side and catheter-securing side of the platform. The pair of catheter fasteners is on the catheter-securing side of the platform. The catheter fasteners are configured to secure a hub of an integrated catheter having an extension port. The pair of stabilization wings extend from a transverse axis of the platform. The stabilization wings are configured to mitigate rotation of the integrated catheter about a longitudinal axis thereof when the integrated catheter is secured by the catheter fasteners on the platform and the stabilization device is adhered to a patient.
In some embodiments, the platform is configured with a degree of flexibility enabling the platform to conform to a contour of the patient at a stabilization site thereof.
In some embodiments, the skin-facing side of the platform has an adhesive thereon configured to adhere to skin of the patient.
In some embodiments, the stabilization device further includes a pad of a foam-like material having a skin-facing side and a platform-facing side of the pad. The pad is configured with a degree of compressibility enabling the pad to conform to a contour of the patient at a stabilization site thereof.
In some embodiments, the skin-facing side of the pad has an adhesive thereon configured to adhere to skin of the patient.
In some embodiments, the catheter fasteners are spaced apart from each other to accommodate the extension port of the integrated catheter between the catheter fasteners when the integrated catheter is secured by the catheter fasteners on the platform.
In some embodiments, at least one catheter fastener of the pair of catheter fasteners is a ‘C’-shaped clip connected to the catheter-securing side of the platform.
In some embodiments, at least one catheter fastener of the pair of catheter fasteners is a clamp having a first jaw connected to the catheter-securing side of the platform and a second jaw connected to the first jaw by a living hinge.
In some embodiments, the platform includes a plurality of through holes configured to enable moisture between the stabilization device and the patient to escape through the through holes when the stabilization device is adhered to the patient.
In some embodiments, the transverse axis of the platform is an axis of symmetry of the platform.
Also disclosed herein is a stabilization device for integrated catheters including, in some embodiments, a platform, a pair of catheter fasteners on the platform, and a pair of stabilization wings extending from the platform. The platform is a polymer-based platform having a skin-facing side and catheter-securing side of the platform. The pair of catheter fasteners is on the catheter-securing side of the platform. The catheter fasteners are configured to secure a hub of an integrated catheter having an extension port. The pair of stabilization wings extend from a transverse axis of the platform. The stabilization wings are configured to mitigate rotation of the integrated catheter about a longitudinal axis thereof when the integrated catheter is secured by the catheter fasteners on the platform and the stabilization device is adhered to a patient. The platform having twofold symmetry about the transverse axis of the platform.
In some embodiments, the platform is configured with a degree of flexibility enabling the platform to conform to a contour of the patient at a stabilization site thereof. The skin-facing side of the platform has an adhesive thereon configured to adhere to skin of the patient.
In some embodiments, the stabilization device further includes a pad of a foam-like material having a skin-facing side and a platform-facing side of the pad. The pad is configured with a degree of compressibility enabling the pad to conform to a contour of the patient at a stabilization site thereof. The skin-facing side of the pad has an adhesive thereon configured to adhere to skin of the patient.
In some embodiments, the catheter fasteners are spaced apart from each other to accommodate the extension port of the integrated catheter between the catheter fasteners when the integrated catheter is secured by the catheter fasteners on the platform.
In some embodiments, at least one catheter fastener of the pair of catheter fasteners is a ‘C’-shaped clip connected to the catheter-securing side of the platform. The ‘C’-shaped clip is configured with a degree of flexibility enabling an opening of the ‘C’-shaped clip to initially expand when the hub of the integrated catheter is inserted into the opening and subsequently contract when the hub of the integrated catheter is inserted past the opening.
In some embodiments, at least one catheter fastener of the pair of catheter fasteners is a clamp having a first jaw connected to the catheter-securing side of the platform and a second jaw connected to the first jaw by a living hinge. The clamp is configured with a snap between the first jaw and the second jaw configured to snap the first and second jaws together after the hub of the integrated catheter is inserted into the clamp.
In some embodiments, the platform includes a plurality of through holes configured to enable moisture between the stabilization device and the patient to escape through the through holes when the stabilization device is adhered to the patient.
Also disclosed herein is a method for stabilizing integrated catheters including, in some embodiments, securing a hub of an integrated catheter in a pair of catheter fasteners on a catheter-securing side of a platform of a stabilization device, the catheter fasteners spaced apart from each other to accommodate an extension port of the integrated catheter between the catheter fasteners; removing an adhesive backing from a skin-facing side of the stabilization device to expose an adhesive; and adhering the stabilization device to skin at a stabilization site near a percutaneous insertion site of a patient, thereby stabilizing the integrated catheter and decreasing risk of mechanical phlebitis.
In some embodiments, securing the hub of the integrated catheter in the pair of catheter fasteners includes expanding an opening of at least one ‘C’-shaped clip of the pair of catheter fasteners upon inserting the hub into the ‘C’-shaped clip and allowing the opening of the ‘C’-shaped clip to contract upon inserting the hub past the opening of the of the ‘C’-shaped clip.
In some embodiments, securing the hub of the integrated catheter in the pair of catheter fasteners includes enclosing the hub within at least one clamp of the pair of catheter fasteners and snapping the clamp closed around the hub. The clamp has a first jaw connected to the catheter-securing side of the platform and a second jaw connected to the first jaw by a living hinge.
In some embodiments, the methods further includes degreasing the patient's skin at the stabilization site with a degreasing wipe before adhering the platform to the skin of the patient.
These and other features of the concepts provided herein will become more apparent to those of skill in the art in view of the accompanying drawings and following description, which disclose particular embodiments of such concepts in greater detail.
Before some particular embodiments are disclosed in greater detail, it should be understood that the particular embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that a particular embodiment disclosed herein can have features that can be readily separated from the particular embodiment and optionally combined with or substituted for features of any of a number of other embodiments disclosed herein.
With respect to terms used herein, it should also be understood the terms are for the purpose of describing some particular embodiments, and the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a group of features or steps, and do not supply a serial or numerical limitation. For example, “first,” “second,” and “third” features or steps need not necessarily appear in that order, and the particular embodiments including such features or steps need not necessarily be limited to the three features or steps. Labels such as “left,” “right,” “top,” “bottom,” “front,” “back,” and the like are used for convenience and are not intended to imply, for example, any particular fixed location, orientation, or direction. Instead, such labels are used to reflect, for example, relative location, orientation, or directions. Singular forms of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.
With respect to “integrated catheter,” an integrated catheter is a one-piece manufacturer-assembled device including a catheter tube fluidly connected to at least one extension tube by way of a hub therebetween. Such an integrated catheter is shown in
With respect to “proximal,” as in a “proximal portion” or a “proximal end portion” of, for example, a catheter disclosed herein, “proximal” refers to a portion of the catheter intended to be near a clinician when the catheter is used on a patient. Likewise, a “proximal length” of, for example, the catheter includes a length of the catheter intended to be near the clinician when the catheter is used on the patient. A “proximal end” of, for example, the catheter includes an end of the catheter intended to be near the clinician when the catheter is used on the patient. The proximal portion, the proximal end portion, or the proximal length of the catheter can include the proximal end of the catheter; however, the proximal portion, the proximal end portion, or the proximal length of the catheter need not include the proximal end of the catheter. That is, unless context suggests otherwise, the proximal portion, the proximal end portion, or the proximal length of the catheter is not a terminal portion or terminal length of the catheter.
With respect to “distal,” as in a “distal portion” or a “distal end portion” of, for example, a catheter disclosed herein, “distal” refers to a portion of the catheter intended to be near or in a patient when the catheter is used on the patient. Likewise, a “distal length” of, for example, the catheter includes a length of the catheter intended to be near or in the patient when the catheter is used on the patient. A “distal end” of, for example, the catheter includes an end of the catheter intended to be near or in the patient when the catheter is used on the patient. The distal portion, the distal end portion, or the distal length of the catheter can include the distal end of the catheter; however, the distal portion, the distal end portion, or the distal length of the catheter need not include the distal end of the catheter. That is, unless context suggests otherwise, the distal portion, the distal end portion, or the distal length of the catheter is not a terminal portion or terminal length of the catheter.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.
Again, a PIVC often needs to be prematurely removed from a patient before an intended IV therapy is complete. A primary factor contributing to the need to prematurely remove a PIVC is mechanical phlebitis, which results when the PIVC moves and irritates the internal anatomy of the patient. A secondary factor contributing to the need to prematurely remove a PIVC is potential introduction of microorganisms when the PIVC moves while within the patient. Mechanical stabilization of PIVCs has been shown to decrease mechanical phlebitis and increase IV-therapy dwell time. However, existing stabilization devices for such PIVCs are not compatible with integrated PIVCs. Thus, the existing stabilization devices cannot provide the mechanical stabilization needed to reduce mechanical phlebitis and enhance the dwell time needed to complete intended IV therapies with integrated PIVCs. Disclosed herein is a stabilization device and methods thereof for integrated catheters such as integrated PIVCs.
For example, a stabilization device for integrated catheters is disclosed including, in some embodiments, a platform, a pair of catheter fasteners on the platform, and a pair of stabilization wings extending from the platform. The platform has a skin-facing side and catheter-securing side of the platform. The pair of catheter fasteners is on the catheter-securing side of the platform. The catheter fasteners are configured to secure a hub of an integrated catheter having an extension port. The pair of stabilization wings extend from a transverse axis of the platform. The stabilization wings are configured to mitigate rotation of the integrated catheter about a longitudinal axis thereof when the integrated catheter is secured by the catheter fasteners on the platform and the stabilization device is adhered to a patient. Also, a method for stabilizing integrated catheters with the stabilization device is disclosed.
Stabilization Device
As shown in
Also shown in
For expository expediency, “the stabilization device 100” of
As shown in
As shown in
As shown in
As shown in
As shown in
The skin-facing side 104 of the platform 510 includes an adhesive (e.g., pressure-sensitive adhesive) thereon configured to adhere to the skin of the patient as with the stabilization device 700 of
With respect to the pad 130, the pad 130 of the stabilization device 100 is formed of a medically acceptable foam-like material having a degree of compressibility also enabling the pad 130 to conform to a contour (e.g., a body contour) of a patient at a stabilization site thereof near a percutaneous insertion site for the integrated catheter 10. Again, the skin-facing side 104 of the pad 130 includes an adhesive (e.g., pressure-sensitive adhesive) thereon configured to adhere to the skin of the patient. (See, for example, the stabilization device 200 of
As shown in
The platform 110, 510, or 610 is formed of a polymeric material such as by injection molding. For example, the platform 510, which is relatively thin and flexible compared to the platform 110, can be formed by injection molding including thin-wall molding. The pair of catheter fasteners 120 can be molded together with the platform 110, 510, or 610 or coupled to the platform 110, 510, or 610 after each of the pair of fasteners 120 and the platform 110, 510, or 610 is molded.
In view of the foregoing description, it should be understood any platform 110, 510, or 610, or a combination thereof, disposed on the pad 130 or not, can include any pair of catheter fasteners 120 described herein to form a stabilization device such as the stabilization device 200, 300, 700, or 800.
Kit
The stabilization device 100, instructions for use of the stabilization device 100, and any one or more additional components selected from the integrated catheter 10, an antimicrobial pad (e.g., BIOPATCH®, GuardIVa®), a topical medicament optionally including an antimicrobial agent, a skin adhesive optionally including an antimicrobial agent, and a degreasing wipe can be packaged as a ready-to-use stabilization kit.
Method
A method for stabilizing integrated catheters such as the integrated catheter 10 includes, in some embodiments, securing the hub 14 of the integrated catheter 10 in the pair of catheter fasteners 120 on the catheter-securing side 104 of the platform 110 of the stabilization device 100, the catheter fasteners 120 spaced apart from each other to accommodate the extension port 16 of the integrated catheter 10 between the catheter fasteners 120; removing an adhesive backing 140 from the skin-facing side 102 of the stabilization device 100 to expose the adhesive; and adhering the stabilization device 100 to skin of the patient at a stabilization site thereof near a percutaneous insertion site, thereby stabilizing the integrated catheter 10 and decreasing risk of mechanical phlebitis.
Securing the hub 14 of the integrated catheter 10 in the pair of catheter fasteners 120 includes expanding the opening of the ‘C’-shaped clip 222 of the pair of catheter fasteners 120 upon inserting the hub 14 into the ‘C’-shaped clip 222 and allowing the opening of the ‘C’-shaped clip 222 to contract upon inserting the hub 14 past the opening of the of the ‘C’-shaped clip 222. Alternatively, securing the hub 14 of the integrated catheter 10 in the pair of catheter fasteners 120 includes enclosing the hub 14 within the clamp 322 of the pair of catheter fasteners 120 and snapping the clamp 322 closed around the hub 14.
The method can further include accessing the percutaneous insertion site in one or more ways of accessing the insertion site such as passing the catheter tube 12 of the integrated catheter 10 into the insertion site.
The method can further include treating the percutaneous insertion site after accessing the insertion site. Treating the insertion site can include placing the antimicrobial pad (e.g., BIOPATCH®, GuardIVa®) around the insertion site to keep the insertion site free of infection. Treating the insertion site can include applying the topical medicament optionally including the antimicrobial agent around the insertion site or sealing the insertion site with the skin adhesive optionally including a same or different antimicrobial agent. Not only does sealing the insertion site with the skin adhesive prevent microbes from entering the insertion site, but sealing the insertion site has the added effect of further stabilizing the integrated catheter 10 to the patient, thereby further decreasing mechanical phlebitis.
The method can further include degreasing the skin of the patient at the stabilization site with a degreasing wipe before adhering the stabilization device 100 to the skin of the patient.
While some particular embodiments have been disclosed herein, and while the particular embodiments have been disclosed in some detail, it is not the intention for the particular embodiments to limit the scope of the concepts provided herein. Additional adaptations and/or modifications can appear to those of ordinary skill in the art, and, in broader aspects, these adaptations and/or modifications are encompassed as well. Accordingly, departures may be made from the particular embodiments disclosed herein without departing from the scope of the concepts provided herein.
This application is a continuation of U.S. patent application Ser. No. 16/825,834, filed Mar. 20, 2020, now U.S. Pat. No. 11,426,557, which claims the benefit of priority to U.S. Provisional Application No. 62/822,721, filed Mar. 22, 2019, each of which is incorporated by reference in its entirety into this application.
| Number | Name | Date | Kind |
|---|---|---|---|
| 6663600 | Bierman et al. | Dec 2003 | B2 |
| 6673046 | Bierman et al. | Jan 2004 | B2 |
| 6689104 | Bierman | Feb 2004 | B2 |
| 6796310 | Bierman | Sep 2004 | B2 |
| 6827705 | Bierman | Dec 2004 | B2 |
| 6827707 | Wright et al. | Dec 2004 | B2 |
| 6866652 | Bierman | Mar 2005 | B2 |
| 6929625 | Bierman | Aug 2005 | B2 |
| 6948500 | Bierman | Sep 2005 | B2 |
| 6951550 | Bierman | Oct 2005 | B2 |
| 6972003 | Bierman et al. | Dec 2005 | B2 |
| 6979320 | Bierman | Dec 2005 | B2 |
| 7014627 | Bierman | Mar 2006 | B2 |
| 7018362 | Bierman et al. | Mar 2006 | B2 |
| 7153291 | Bierman | Dec 2006 | B2 |
| 7204827 | Kessler | Apr 2007 | B2 |
| 7223256 | Bierman | May 2007 | B2 |
| 7247150 | Bierman | Jul 2007 | B2 |
| 7354421 | Bierman | Apr 2008 | B2 |
| 7491190 | Bierman et al. | Feb 2009 | B2 |
| 7520870 | Bierman | Apr 2009 | B2 |
| 7563251 | Bierman et al. | Jul 2009 | B2 |
| 7568484 | Bierman et al. | Aug 2009 | B2 |
| 7578804 | Bierman | Aug 2009 | B2 |
| 7591803 | Bierman | Sep 2009 | B2 |
| 7628154 | Bierman et al. | Dec 2009 | B2 |
| 7628771 | Kessler | Dec 2009 | B2 |
| 7635355 | Bierman | Dec 2009 | B2 |
| 7648492 | Bierman | Jan 2010 | B2 |
| 7651479 | Bierman | Jan 2010 | B2 |
| 7666167 | Bierman | Feb 2010 | B2 |
| 7722571 | Bierman et al. | May 2010 | B2 |
| 7744572 | Bierman | Jun 2010 | B2 |
| 7762991 | Bierman et al. | Jul 2010 | B2 |
| 7785295 | Bierman | Aug 2010 | B2 |
| 7799001 | Bierman | Sep 2010 | B2 |
| 7806873 | Dikeman et al. | Oct 2010 | B2 |
| 7811258 | Bierman | Oct 2010 | B2 |
| 7837655 | Bierman et al. | Nov 2010 | B2 |
| 7879013 | Smith et al. | Feb 2011 | B2 |
| 7887515 | Bierman | Feb 2011 | B2 |
| 7935083 | Bierman et al. | May 2011 | B2 |
| 7935084 | Bierman | May 2011 | B2 |
| 7955307 | Bierman et al. | Jun 2011 | B2 |
| 7967792 | Bierman | Jun 2011 | B2 |
| 7972310 | Kessler | Jul 2011 | B2 |
| 7985206 | Dikeman et al. | Jul 2011 | B2 |
| 7988673 | Wright et al. | Aug 2011 | B2 |
| 8016792 | Wright et al. | Sep 2011 | B2 |
| 8016793 | Wright et al. | Sep 2011 | B2 |
| 8025060 | Bierman | Sep 2011 | B2 |
| 8025643 | Bierman | Sep 2011 | B2 |
| 8043280 | Bierman | Oct 2011 | B2 |
| 8052648 | Dikeman et al. | Nov 2011 | B2 |
| 8052649 | Wright | Nov 2011 | B2 |
| 8052652 | Bierman et al. | Nov 2011 | B2 |
| 8057440 | Bierman | Nov 2011 | B2 |
| 8074651 | Bierman et al. | Dec 2011 | B2 |
| 8100862 | Bierman | Jan 2012 | B2 |
| 8105289 | Bierman et al. | Jan 2012 | B2 |
| 8105290 | Wright et al. | Jan 2012 | B2 |
| 8114054 | Bierman et al. | Feb 2012 | B2 |
| 8146210 | Nishtala | Apr 2012 | B2 |
| 8162898 | Wright | Apr 2012 | B1 |
| 8172807 | Dikeman et al. | May 2012 | B2 |
| 8177756 | Wright | May 2012 | B2 |
| 8197447 | Wright | Jun 2012 | B2 |
| 8211063 | Bierman et al. | Jul 2012 | B2 |
| 8241253 | Bracken | Aug 2012 | B2 |
| 8246583 | Bierman | Aug 2012 | B2 |
| 8251956 | Bierman et al. | Aug 2012 | B2 |
| 8269059 | Wright et al. | Sep 2012 | B2 |
| 8277420 | Bierman et al. | Oct 2012 | B2 |
| 8282606 | Bierman | Oct 2012 | B2 |
| 8298191 | Bierman et al. | Oct 2012 | B2 |
| 8333736 | Wright et al. | Dec 2012 | B2 |
| 8357124 | Bierman | Jan 2013 | B2 |
| 8366678 | Bierman et al. | Feb 2013 | B2 |
| 8394065 | Bierman | Mar 2013 | B2 |
| 8394067 | Bracken et al. | Mar 2013 | B2 |
| 8398599 | Bierman | Mar 2013 | B2 |
| 8465458 | Bierman | Jun 2013 | B2 |
| 8506531 | Bierman | Aug 2013 | B2 |
| 8540680 | Burn | Sep 2013 | B2 |
| 8585655 | Bierman | Nov 2013 | B2 |
| 8608704 | Bierman | Dec 2013 | B2 |
| 8608705 | Peters et al. | Dec 2013 | B2 |
| 8636698 | Bierman et al. | Jan 2014 | B2 |
| 8636701 | Henry et al. | Jan 2014 | B2 |
| 8641678 | Bierman | Feb 2014 | B2 |
| 8657791 | Bierman et al. | Feb 2014 | B2 |
| 8679066 | Aviles | Mar 2014 | B2 |
| 8679067 | Wright | Mar 2014 | B2 |
| 8684976 | Bierman et al. | Apr 2014 | B2 |
| 8708967 | Bierman | Apr 2014 | B2 |
| 8728039 | Bierman et al. | May 2014 | B2 |
| 8734400 | Ciccone | May 2014 | B2 |
| 8740852 | Aviles | Jun 2014 | B2 |
| 8827959 | Wright et al. | Sep 2014 | B2 |
| 8834424 | Parvatiyar et al. | Sep 2014 | B2 |
| 8834425 | Bracken et al. | Sep 2014 | B2 |
| 8840589 | Bierman et al. | Sep 2014 | B2 |
| 8900196 | Andino | Dec 2014 | B2 |
| 8915885 | Smith et al. | Dec 2014 | B2 |
| 9017290 | Peters et al. | Apr 2015 | B2 |
| 9056186 | Wright et al. | Jun 2015 | B2 |
| 9061122 | Bierman et al. | Jun 2015 | B2 |
| 9067013 | Wright et al. | Jun 2015 | B2 |
| 9138560 | Wright et al. | Sep 2015 | B2 |
| 9415191 | Aviles | Aug 2016 | B2 |
| 9468740 | Bierman et al. | Oct 2016 | B2 |
| 9480821 | Ciccone et al. | Nov 2016 | B2 |
| 9526871 | Wright et al. | Dec 2016 | B2 |
| 9561348 | Bierman | Feb 2017 | B2 |
| 9604034 | Andino | Mar 2017 | B2 |
| 9616200 | Smith et al. | Apr 2017 | B2 |
| 9642987 | Bierman et al. | May 2017 | B2 |
| 9694130 | Andino et al. | Jul 2017 | B2 |
| 9700700 | Andino et al. | Jul 2017 | B2 |
| 9731097 | Andino et al. | Aug 2017 | B2 |
| 9962524 | Andino | May 2018 | B2 |
| 9974929 | Ciccone et al. | May 2018 | B2 |
| 9993619 | Bracken et al. | Jun 2018 | B2 |
| 10245415 | Andino et al. | Apr 2019 | B2 |
| 10322262 | Bracken et al. | Jun 2019 | B2 |
| 10426928 | Andino et al. | Oct 2019 | B2 |
| 10537714 | Andino et al. | Jan 2020 | B2 |
| 10561815 | Bierman et al. | Feb 2020 | B2 |
| 10589067 | Ciccone | Mar 2020 | B2 |
| 10729887 | Andino et al. | Aug 2020 | B2 |
| 11020565 | Spitler | Jun 2021 | B2 |
| 11420023 | Andino et al. | Aug 2022 | B2 |
| 11426557 | Naidu | Aug 2022 | B2 |
| 20020068904 | Bierman et al. | Jun 2002 | A1 |
| 20020133121 | Bierman | Sep 2002 | A1 |
| 20020165493 | Bierman | Nov 2002 | A1 |
| 20020165494 | Bierman et al. | Nov 2002 | A1 |
| 20020187259 | Bierman | Dec 2002 | A1 |
| 20020188255 | Bierman et al. | Dec 2002 | A1 |
| 20020188257 | Bierman | Dec 2002 | A1 |
| 20030083625 | Bierman | May 2003 | A1 |
| 20030089374 | Bierman | May 2003 | A1 |
| 20030125668 | Bierman | Jul 2003 | A1 |
| 20030229313 | Bierman | Dec 2003 | A1 |
| 20040034330 | Bierman et al. | Feb 2004 | A1 |
| 20040102736 | Bierman | May 2004 | A1 |
| 20040138624 | Bierman | Jul 2004 | A1 |
| 20040167475 | Wright et al. | Aug 2004 | A1 |
| 20040199122 | Bierman et al. | Oct 2004 | A1 |
| 20040204684 | Bierman | Oct 2004 | A1 |
| 20040226565 | Bierman | Nov 2004 | A1 |
| 20050010173 | Bierman et al. | Jan 2005 | A1 |
| 20050027258 | Bierman et al. | Feb 2005 | A1 |
| 20050075610 | Bierman | Apr 2005 | A1 |
| 20050131351 | Bierman | Jun 2005 | A1 |
| 20050192539 | Bierman et al. | Sep 2005 | A1 |
| 20050192540 | Kessler | Sep 2005 | A1 |
| 20050263158 | Bierman | Dec 2005 | A1 |
| 20050273058 | Bierman | Dec 2005 | A1 |
| 20060064063 | Bierman | Mar 2006 | A1 |
| 20060089600 | Bierman et al. | Apr 2006 | A1 |
| 20060124133 | Bierman et al. | Jun 2006 | A1 |
| 20060129103 | Bierman et al. | Jun 2006 | A1 |
| 20060135944 | Bierman | Jun 2006 | A1 |
| 20060184127 | Bierman | Aug 2006 | A1 |
| 20060184128 | Bierman | Aug 2006 | A1 |
| 20060184129 | Bierman | Aug 2006 | A1 |
| 20060247577 | Wright | Nov 2006 | A1 |
| 20060264836 | Bierman | Nov 2006 | A1 |
| 20060270994 | Bierman | Nov 2006 | A1 |
| 20060270995 | Bierman | Nov 2006 | A1 |
| 20060276752 | Bierman et al. | Dec 2006 | A1 |
| 20070055205 | Wright et al. | Mar 2007 | A1 |
| 20070066958 | Wright | Mar 2007 | A1 |
| 20070068533 | Bierman et al. | Mar 2007 | A1 |
| 20070088329 | Bierman | Apr 2007 | A1 |
| 20070142784 | Dikeman et al. | Jun 2007 | A1 |
| 20070149930 | Bierman | Jun 2007 | A1 |
| 20070156097 | Bierman | Jul 2007 | A1 |
| 20070167915 | Bierman | Jul 2007 | A1 |
| 20070173766 | Bierman | Jul 2007 | A1 |
| 20070173769 | Kessler | Jul 2007 | A1 |
| 20070219500 | Wright et al. | Sep 2007 | A1 |
| 20070265572 | Smith et al. | Nov 2007 | A1 |
| 20070276332 | Bierman | Nov 2007 | A1 |
| 20070276333 | Bierman | Nov 2007 | A1 |
| 20070276334 | Bierman et al. | Nov 2007 | A1 |
| 20070276335 | Bierman | Nov 2007 | A1 |
| 20070276336 | Bierman et al. | Nov 2007 | A1 |
| 20070282273 | Bierman | Dec 2007 | A1 |
| 20070287963 | Bierman | Dec 2007 | A1 |
| 20080027391 | Bierman | Jan 2008 | A1 |
| 20080027392 | Bierman | Jan 2008 | A1 |
| 20080027393 | Bierman | Jan 2008 | A1 |
| 20080027394 | Bierman | Jan 2008 | A1 |
| 20080039798 | Bierman | Feb 2008 | A1 |
| 20080077118 | Bierman | Mar 2008 | A1 |
| 20080097334 | Dikeman et al. | Apr 2008 | A1 |
| 20080132848 | Wright et al. | Jun 2008 | A1 |
| 20080154208 | Bierman | Jun 2008 | A1 |
| 20080249476 | Bierman et al. | Oct 2008 | A1 |
| 20090036835 | Bierman | Feb 2009 | A1 |
| 20090043260 | Bierman | Feb 2009 | A1 |
| 20090093766 | Bierman et al. | Apr 2009 | A1 |
| 20090093769 | Wright et al. | Apr 2009 | A1 |
| 20090137961 | Bracken | May 2009 | A1 |
| 20090137962 | Bracken et al. | May 2009 | A1 |
| 20090139061 | Nishtala | Jun 2009 | A1 |
| 20090143740 | Bierman et al. | Jun 2009 | A1 |
| 20090143741 | Bum | Jun 2009 | A1 |
| 20090143742 | Bracken et al. | Jun 2009 | A1 |
| 20090143744 | Bierman et al. | Jun 2009 | A1 |
| 20090145440 | Bierman et al. | Jun 2009 | A1 |
| 20090182283 | Sloan | Jul 2009 | A1 |
| 20090254040 | Bierman et al. | Oct 2009 | A1 |
| 20090259188 | Bierman et al. | Oct 2009 | A1 |
| 20090306603 | Bierman et al. | Dec 2009 | A1 |
| 20090326474 | Bierman et al. | Dec 2009 | A1 |
| 20100022962 | Bierman et al. | Jan 2010 | A1 |
| 20100100051 | Bierman | Apr 2010 | A1 |
| 20100114034 | Wright et al. | May 2010 | A1 |
| 20100137807 | Kessler | Jun 2010 | A1 |
| 20100179481 | Bierman et al. | Jul 2010 | A1 |
| 20100179482 | Wright et al. | Jul 2010 | A1 |
| 20100179483 | Wright et al. | Jul 2010 | A1 |
| 20100180900 | Talsma et al. | Jul 2010 | A1 |
| 20100222748 | Bierman et al. | Sep 2010 | A1 |
| 20100298777 | Nishtala | Nov 2010 | A1 |
| 20100298778 | Bracken et al. | Nov 2010 | A1 |
| 20100324491 | Bierman et al. | Dec 2010 | A1 |
| 20110021998 | Dikeman et al. | Jan 2011 | A1 |
| 20110054409 | Nishtala | Mar 2011 | A1 |
| 20110112483 | Smith et al. | May 2011 | A1 |
| 20110178467 | Bierman et al. | Jul 2011 | A1 |
| 20110202010 | Bierman | Aug 2011 | A1 |
| 20110213310 | Bierman | Sep 2011 | A1 |
| 20110218498 | Bierman et al. | Sep 2011 | A1 |
| 20110230843 | Bierman et al. | Sep 2011 | A1 |
| 20110240034 | Ciccone | Oct 2011 | A1 |
| 20110245777 | Andino et al. | Oct 2011 | A1 |
| 20110257600 | Kessler | Oct 2011 | A1 |
| 20110264050 | Henry et al. | Oct 2011 | A1 |
| 20110282291 | Ciccone | Nov 2011 | A1 |
| 20110282294 | Dikeman et al. | Nov 2011 | A1 |
| 20110288487 | Wright et al. | Nov 2011 | A1 |
| 20110288489 | Bierman et al. | Nov 2011 | A1 |
| 20110295173 | Wright et al. | Dec 2011 | A1 |
| 20110295210 | Wright | Dec 2011 | A1 |
| 20110313362 | Bierman | Dec 2011 | A1 |
| 20110319830 | Peters et al. | Dec 2011 | A1 |
| 20120029484 | Gusmao et al. | Feb 2012 | A1 |
| 20120041378 | Bierman | Feb 2012 | A1 |
| 20120046649 | Bierman | Feb 2012 | A1 |
| 20120053526 | Bierman et al. | Mar 2012 | A1 |
| 20120059328 | Dikeman et al. | Mar 2012 | A1 |
| 20120059329 | Bierman | Mar 2012 | A1 |
| 20120123343 | Aviles | May 2012 | A1 |
| 20120136314 | Ciccone et al. | May 2012 | A1 |
| 20120143140 | Bierman et al. | Jun 2012 | A1 |
| 20120150117 | Andino | Jun 2012 | A1 |
| 20120184915 | Bierman et al. | Jul 2012 | A1 |
| 20120197202 | Wright et al. | Aug 2012 | A1 |
| 20120197205 | Peters | Aug 2012 | A1 |
| 20120215173 | Wright | Aug 2012 | A1 |
| 20120220947 | Dikeman et al. | Aug 2012 | A1 |
| 20120232488 | Aviles | Sep 2012 | A1 |
| 20120232490 | Andino | Sep 2012 | A1 |
| 20120265147 | Andino et al. | Oct 2012 | A1 |
| 20120271237 | Andino | Oct 2012 | A1 |
| 20120271239 | Andino et al. | Oct 2012 | A1 |
| 20120271240 | Andino et al. | Oct 2012 | A1 |
| 20120316505 | Wright | Dec 2012 | A1 |
| 20130018322 | Wright et al. | Jan 2013 | A1 |
| 20130053785 | Parvatiyar et al. | Feb 2013 | A1 |
| 20130079723 | Andino et al. | Mar 2013 | A1 |
| 20130138045 | Bierman | May 2013 | A1 |
| 20130138080 | Andino et al. | May 2013 | A1 |
| 20130150827 | Bracken et al. | Jun 2013 | A1 |
| 20130345639 | Spittler | Dec 2013 | A1 |
| 20140188078 | Peters et al. | Jul 2014 | A1 |
| 20140249478 | Bierman et al. | Sep 2014 | A1 |
| 20140276542 | Ciccone | Sep 2014 | A1 |
| 20140276544 | Aviles | Sep 2014 | A1 |
| 20140343501 | Bierman et al. | Nov 2014 | A1 |
| 20150088076 | Andino | Mar 2015 | A1 |
| 20150112270 | Smith et al. | Apr 2015 | A1 |
| 20150367102 | Andino et al. | Dec 2015 | A1 |
| 20160008577 | Wright et al. | Jan 2016 | A1 |
| 20170043131 | Ciccone et al. | Feb 2017 | A1 |
| 20170216556 | Bierman et al. | Aug 2017 | A1 |
| 20170296788 | Andino et al. | Oct 2017 | A1 |
| 20170296789 | Andino et al. | Oct 2017 | A1 |
| 20190247625 | Bracken et al. | Aug 2019 | A1 |
| 20200030578 | Andino et al. | Jan 2020 | A1 |
| 20200171273 | Bierman et al. | Jun 2020 | A1 |
| 20200215309 | Ciccone | Jul 2020 | A1 |
| 20200297975 | Naidu | Sep 2020 | A1 |
| 20200324085 | Andino et al. | Oct 2020 | A1 |
| 20210283375 | Spitler | Sep 2021 | A1 |
| Number | Date | Country |
|---|---|---|
| 2264219 | Dec 2006 | ES |
| 2015134250 | Sep 2015 | WO |
| Entry |
|---|
| PCT/US2020/024010 filed Mar. 20, 2020 International Search Report and Written Opinion dated Jun. 2, 2020. |
| uS16/825,834 filed Mar. 20, 2020 Non-Final Office Action dated Nov. 4, 2021. |
| uS16/825,834 filed Mar. 20, 2020 Notice of Allowance dated Apr. 13, 2022. |
| EP 207797853 filed Sep. 30, 2021 Extended European Search Report dated Nov. 21, 2022. |
| Number | Date | Country | |
|---|---|---|---|
| 20220409862 A1 | Dec 2022 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62822721 | Mar 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16825834 | Mar 2020 | US |
| Child | 17898337 | US |